Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Sales | 85 | 100 | 135 | 131 | 115 |
| Cost of Goods | 6 | 5 | 73 | 143 | 132 |
| Gross Profit | 80 | 95 | 62 | -12 | -17 |
| Operating Expenses | 3,852 | 2,750 | 3,952 | 4,332 | 4,921 |
| Operating Income | -3,767 | -2,650 | -3,817 | -4,201 | -4,806 |
| Interest Expense | 2,722 | 257 | 12 | 1,288 | 4,123 |
| Other Income | 549 | -467 | 1,174 | -5,398 | 6,015 |
| Pre-tax Income | -5,939 | -3,374 | -2,655 | -10,887 | -2,914 |
| Income Tax | 2 | 5 | 5 | 1 | 2 |
| Net Income Continuous | -5,941 | -3,379 | -2,660 | -10,888 | -2,916 |
| Net Income Discontinuous | N/A | N/A | -3 | -19 | -491 |
| Net Income | $-5,941 | $-3,379 | $-2,663 | $-10,907 | $-3,407 |
| EPS Basic Total Ops | -55.55 | -39.83 | -35.99 | -167.97 | -2,171.57 |
| EPS Basic Continuous Ops | -55.51 | -39.83 | -35.99 | -167.97 | -1,859.63 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.00 | 0.00 | -311.94 |
| EPS Diluted Total Ops | -55.55 | -39.83 | -35.99 | -167.97 | -2,171.57 |
| EPS Diluted Continuous Ops | -55.51 | -39.83 | -35.99 | -167.97 | -1,859.63 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.00 | 0.00 | -311.94 |
| EBITDA(a) | $-3,760 | $-2,642 | $-3,802 | $-3,525 | $-1,243 |